Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Thoracic and Cardiovascular Surgery

• Publication date

  2009-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jtcvs.2009.02.046PMID 19619785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.

  2009cited by this paper
• Radical surgery for malignant pleural mesothelioma: results and prognosis.

  2008cited by this paper
• Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

  2008cited by this paper
• Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.

  2007cited by this paper
• Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma.

  2006cited by this paper
• Induction Chemotherapy, Extrapleural Pneumonectomy, and Postoperative High-Dose Radiotherapy for Locally Advanced Malignant Pleural Mesothelioma: A Phase II Trial

  2006cited by this paper
• Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.

  2006cited by this paper
• Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.

  2006cited by this paper
• The Use of Chemotherapy in Patients with Advanced Malignant Pleural Mesothelioma: A Systematic Review and Practice Guideline

  2006cited by this paper
• 178 Sequential amifostine and sodium thiosulfate improve renal protection during intracavitary high-dose cisplatin lavage

  2006cited by this paper
• Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.

  2005cited by this paper
• New therapeutic options for mesothelioma

  2005cited by this paper
• Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma.

  2005cited by this paper
• Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.

  2004cited by this paper
• Global Use of Asbestos and the Incidence of Mesothelioma

  2004cited by this paper
• Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications.

  2004cited by this paper
• Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

  2003cited by this paper
• A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma.

  2003cited by this paper
• Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases.

  2002cited by this paper
• American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.

  1999cited by this paper
• Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

  1999cited by this paper
• Patterns of failure after trimodality therapy for malignant pleural mesothelioma.

  1997cited by this paper
• Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma

  1997cited by this paper
• Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.

  1996cited by this paper
• The importance of surgical staging in the treatment of malignant pleural mesothelioma.

  1996cited by this paper
• Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma.

  1992cited by this paper
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

  1988cited by this paper
• Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protection.

  1985cited by this paper
• Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.

  1976cited by this paper
• [Chances and results of surgery of malignant mesothelioma of the pleura (author's transl)].

  1974cited by this paper

• Hyperthermic intrathoracic chemotherapy (HITHOC): A tertiary oncological center experience

  2025cites this paper
• Hyperthermic Intrathoracic Chemoperfusion and the Role of Adjunct Immunotherapy for the Treatment of Pleural Mesothelioma

  2025influential citation
• Surgical treatment for pleural mesothelioma with hyperthermic intrathoracic chemotherapy: a clinical case

  2025cites this paper
• Hyperthermic intraperitoneal chemotherapy enhances survival outcomes in primary ovarian cancer following cytoreductive surgery: a systematic review and meta-analysis

  2025cites this paper
• Hyperthermic Intrathoracic Chemotherapy and Photodynamic Therapy: A Single-Institution Experience for Malignant Pleural Diseases.

  2025cites this paper
• Cytoreductive surgery and hyperthermic intrathoracic chemotherapy in thymic epithelial tumors with pleural spread or recurrence: a prospective, single-arm, phase II study

  2025cites this paper
• Hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma after cytoreductive surgical procedures: a systematic review

  2025influential citation
• The Role of Surgery in Pleural Mesothelioma

  2024cites this paper
• Comparison of surgical treatment and systemic chemotherapy in patients with non-epithelioid malignant pleural mesothelioma.

  2024cites this paper
• Effect of intraoperative hyperthermic intrathoracic chemotherapy after pleurectomy decortication for treatment of malignant pleural mesothelioma: a comparative study

  2024cites this paper
• Postoperative early laboratory changes and follow-up process of patients underwent hyperthermic intrathoracic chemotherapy

  2024influential citation
• Intracavitary cisplatin-fibrin followed by irradiation improved tumor control compared to the single treatments in a mesothelioma rat model

  2024cites this paper
• The Role of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Thoracic Tumors

  2024cites this paper
• A review of chemotherapeutic drugs-induced arrhythmia and potential intervention with traditional Chinese medicines

  2024cites this paper
• Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect.

  2024cites this paper
• High‐dose IV magnesium in mesothelioma patients receiving surgery with hyperthermic intraoperative cisplatin: Pilot studies and design of a phase II randomized clinical trial

  2023cites this paper
• Hyperthermic intrapleural chemotherapy: an update

  2023cites this paper
• Contemporary issues in the surgical management of pleural mesothelioma

  2023influential citation
• Empiric Flap Coverage for the Pneumonectomy Stump: How Protective Is It? A Single-Institution Cohort Study.

  2023cites this paper
• Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systematic review

  2022cites this paper
• Drug-Induced Atrial Fibrillation / Atrial Flutter

  2022cites this paper
• Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma Tumors

  2022cites this paper
• Atrial Fibrillation in Cancer Patients: Who is at Risk?

  2022cites this paper
• Pleuropneumonectomy as Salvage Therapy in Children Suffering from Primary or Metastatic Sarcomas with Pleural Localizations

  2021cites this paper
• Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial.

  2021cites this paper
• Novel Therapies

  2021cites this paper
• Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy

  2021cites this paper
• Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study

  2021influential citation
• Assessment of concentration and penetration depth of cisplatin in human lung tissue after decortication and hyperthermic exposure

  2021cites this paper
• Hyperthermic intrathoracic chemotherapy in thoracic surgical oncology: future challenges of an exciting procedure.

  2021cites this paper
• Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis

  2021influential citation
• Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma

  2021cites this paper
• Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment

  2021influential citation
• Hyperthermic intrathoracic chemotherapy (HITHOC): narrative review of the current literature, recommendations and future studies

  2021cites this paper
• Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study

  2021cites this paper
• Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany

  2020cites this paper
• Intraoperative Accidents and Postoperative Complications in the Surgery of Pleural Tumours

  2020cites this paper
• Commentary: Cisplatin-induced nephrotoxicity following cytoreductive surgery and heated intraoperative chemotherapy for malignant pleural mesothelioma.

  2020cites this paper
• Updates in Staging and Management of Malignant Pleural Mesothelioma.

  2020cites this paper
• Commentary: Winning the battle for local control without losing war for survival against malignant pleural mesothelioma.

  2020cites this paper
• Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin

  2020cites this paper
• Atrial Fibrillation Associated with Anticancer Drugs

  2020cites this paper
• Extrapleural pneumonectomies for pleural mesothelioma

  2020influential citation
• Extra-pleural pneumonectomy.

  2019influential citation
• Adequate nephroprotection reduces renal complications after hyperthermic intrathoracic chemotherapy

  2019influential citation
• Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial.

  2019cites this paper
• Feasibility trial assessing intrapleural photodynamic therapy combined with pleurectomy/decortication then chemotherapy in malignant pleural mesothelioma patients

  2019cites this paper
• Surgery and Multimodality Treatment in Malignant Pleural Mesothelioma

  2019cites this paper
• Expertenempfehlung zur Anwendung der hyperthermen intrathorakalen Chemotherapie (HITOC) in Deutschland

  2019influential citation
• Hypertherme intrathorakale Chemotherapie in der Thoraxchirurgie

  2019cites this paper
• Extrapleural Pneumonectomy

  2019cites this paper
• Surgery for Malignant Pleural Mesothelioma

  2019cites this paper
• Preoperative prediction of unresectability in malignant pleural mesothelioma.

  2019cites this paper
• Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

  2019cites this paper
• Mesothelioma

  2019influential citation
• Surgical Cytoreduction and HITOC for Thymic Malignancies with Pleural Dissemination

  2019cites this paper
• Non-Invasive Radiofrequency Field Treatment of 4T1 Breast Tumors Induces T-cell Dependent Inflammatory Response

  2018cites this paper
• Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms

  2018cites this paper
• Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies

  2018cites this paper
• Anwendung der hyperthermen intrathorakalen Chemotherapie (HITHOC) in Deutschland

  2018cites this paper
• Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural Malignancies—Experience from Indian Centers

  2018cites this paper
• Other Thoracic Malignancies

  2018cites this paper
• Intraoperative hypertherme intrathorakale Chemotherapie

  2018cites this paper
• A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma

  2018cites this paper
• Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

  2018cites this paper
• Pleurectomy/decortication versus extrapleural pneumonectomy: a critical choice.

  2018cites this paper
• Induction or adjuvant chemotherapy for radical multimodality therapy

  2018cites this paper
• Hyperthermic intrathoracic chemotherapy (HITHOC) in ovarian carcinoma - a propos of a case.

  2018cites this paper
• Intraoperative intracavitary hyperthermic chemotherapy for malignant pleural mesothelioma.

  2017cites this paper
• Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma

  2017cites this paper
• Diaphragm and lung–preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10‐year experience

  2017cites this paper
• Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis

  2017influential citation
• The seven attributes of the academic surgeon: Critical aspects of the archetype and contributions to the surgical community.

  2017cites this paper
• Overview of treatment related complications in malignant pleural mesothelioma.

  2017cites this paper
• Intraoperative adjuncts for malignant pleural mesothelioma.

  2017cites this paper
• Hump-like giant desmoid tumor of the chest: a postresectional reconstruction challenge.

  2017cites this paper
• Surgery Approaches in Mesothelioma

  2017cites this paper
• Two-Step Delivery: Exploiting the Partition Coefficient Concept to Increase Intratumoral Paclitaxel Concentrations In vivo Using Responsive Nanoparticles

  2016cites this paper
• Current Treatment of Mesothelioma: Extrapleural Pneumonectomy Versus Pleurectomy/Decortication.

  2016cites this paper
• What is the best approach for surgery of malignant pleural mesothelioma? It is to put our efforts into obtaining trustworthy evidence for practice.

  2016cites this paper
• Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma

  2016cites this paper
• PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA

  2016cites this paper
• Chapter 46 – Uncommon Thoracic Tumors

  2016cites this paper
• Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma.

  2016cites this paper
• Management of malignant pleural mesothelioma—part 2: therapeutic approaches

  2016cites this paper
• Hedgehog Signaling in Malignant Pleural Mesothelioma

  2015cites this paper
• Surgery for malignant pleural mesothelioma

  2015cites this paper
• Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.

  2015cites this paper
• Great Vessel Injury in Thoracic Surgery.

  2015cites this paper
• Fifteen years in the evaluation of extrapleural pneumonectomy: Lessons to be learned.

  2015cites this paper
• Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.

  2015cites this paper
• Multimodality therapy for malignant pleural mesothelioma: surgery plus chemoradiotherapy?

  2015cites this paper
• Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.

  2015cites this paper
• Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy

  2015cites this paper
• Changing Pattern in Malignant Mesothelioma Survival

  2015cites this paper
• Assessment of cisplatin concentration and depth of penetration in human lung tissue after hyperthermic exposure.

  2015cites this paper
• Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience.

  2015cites this paper
• Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.

  2015cites this paper
• Extrapleural Pneumonectomy A Blessing or a Curse in the Management of Pleural Malignant Mesothelioma

  2015cites this paper
• Surgical and Medical Therapy for Malignant Pleural Mesothelioma

  2014cites this paper